1. Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer 
Linda E. Coate, MD, Christine Massey, MSc, Andrew Hope, MD, Adrian Sacher, MD, Katherine Barrett, MD, Andrew Pierre, MD, Natasha Leighl, MD, Anthony Brade, MD, Marc de Perrot, MD, Tom Waddell, MD, Geoffrey Liu, MD, Ronald Feld, MD, Ronald Burkes, MD, B. C. John Cho, MD, Gail Darling, MD, Alexander Sun, MD, Shaf Keshavjee, MD, Andrea Bezjak, MD, Frances A. Shepherd, MD, FRCPC 
Journal of Thoracic Oncology 
Volume 6, Issue 3, Pages (March 2011)
DOI: /JTO.0b013e31820b8b9b
Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

2. FIGURE 1
Overall survival according to age. A, Overall survival according to age—entire cohort. B, Overall survival according to age for nonsurgical bimodality therapy. C, Overall survival according to age—surgical multimodality therapy.
Journal of Thoracic Oncology 2011 6, DOI: ( /JTO.0b013e31820b8b9b)
Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions